LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Clinical trial NCT05983250 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05983250
- Sponsor
- Tenax Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-10
- Primary completion
- 2026-06-30
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.